HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Johan P de Winter Selected Research

Fanconi Anemia (Fanconi's Anemia)

2/2015DNA helicases FANCM and DDX11 are determinants of PARP inhibitor sensitivity.
5/2013Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia.
7/2012A ubiquitin-binding protein, FAAP20, links RNF8-mediated ubiquitination to the Fanconi anemia DNA repair network.
1/2012Diagnosis of Fanconi Anemia: Mutation Analysis by Multiplex Ligation-Dependent Probe Amplification and PCR-Based Sanger Sequencing.
2/2011SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype.
2/2010Warsaw breakage syndrome, a cohesinopathy associated with mutations in the XPD helicase family member DDX11/ChlR1.
9/2009Recruitment of fanconi anemia and breast cancer proteins to DNA damage sites is differentially governed by replication.
7/2009Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M.
5/2007Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.
2/2007Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Johan P de Winter Research Topics

Disease

21Fanconi Anemia (Fanconi's Anemia)
02/2015 - 10/2003
13Hypersensitivity (Allergy)
12/2015 - 08/2004
10Neoplasms (Cancer)
12/2015 - 10/2003
6Chromosomal Instability (Chromosome Stability)
12/2015 - 06/2004
4Breast Neoplasms (Breast Cancer)
09/2014 - 10/2003
4Genomic Instability
05/2013 - 01/2005
4Chromosome Breakage
01/2012 - 01/2007
3Bone Marrow Failure Disorders
12/2015 - 08/2004
2Inborn Genetic Diseases (Disease, Hereditary)
12/2015 - 08/2004
2Complementation Group D1 Fanconi Anemia
02/2015 - 01/2006
2Chromosome Aberrations (Chromosome Abnormalities)
01/2013 - 01/2012
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2005 - 08/2004
1XFE Progeroid Syndrome
05/2013
1Xeroderma Pigmentosum (Kaposi's Disease)
05/2013
1Roberts Syndrome
02/2010
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2005
1Infections
08/2004

Drug/Important Bio-Agent (IBA)

20DNA (Deoxyribonucleic Acid)IBA
12/2015 - 10/2003
12Proteins (Proteins, Gene)FDA Link
09/2014 - 10/2003
4Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2012 - 10/2003
4A-Form DNA (A-DNA)IBA
01/2010 - 10/2003
4Fanconi Anemia Complementation Group D2 ProteinIBA
01/2008 - 10/2003
3UbiquitinIBA
07/2012 - 10/2003
3Small Interfering RNA (siRNA)IBA
04/2007 - 01/2007
2Poly(ADP-ribose) Polymerase InhibitorsIBA
02/2015 - 09/2014
2EndonucleasesIBA
05/2013 - 02/2011
2Ligases (Synthetase)IBA
09/2005 - 10/2003
2Cisplatin (Platino)FDA LinkGeneric
01/2005 - 08/2004
1Paclitaxel (Taxol)FDA LinkGeneric
10/2015
1PoisonsIBA
10/2015
1apcinIBA
10/2015
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2014
1Carrier Proteins (Binding Protein)IBA
07/2012
1diepoxybutaneIBA
01/2012
1Histones (Histone)IBA
03/2010
1Pharmaceutical PreparationsIBA
02/2010
1AcetyltransferasesIBA
09/2009
1CamptothecinIBA
07/2009
1ChromatinIBA
02/2007
1Archaeal DNAIBA
09/2005
1PlatinumIBA
01/2005
1Nuclear Proteins (Protein, Nuclear)IBA
11/2004
1Fanconi Anemia Complementation Group G ProteinIBA
01/2004
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
10/2003
1Fanconi Anemia Complementation Group ProteinsIBA
10/2003

Therapy/Procedure

2Therapeutics
01/2005 - 08/2004
1Ligation
01/2012
1Drug Therapy (Chemotherapy)
01/2005